Figures & data
Figure 1 Concepts pertaining to the evaluation of adherence. Adapted with permission from Vrijens B, De Geest S, Hughes DA, et al. A new taxonomy for describing and defining adherence to medications. Br J Clin Pharmacol. 2012;73(5):691–705. © 2012 The Authors. British Journal of Clinical Pharmacology © 2012 The British Pharmacological Society.Citation8
![Figure 1 Concepts pertaining to the evaluation of adherence. Adapted with permission from Vrijens B, De Geest S, Hughes DA, et al. A new taxonomy for describing and defining adherence to medications. Br J Clin Pharmacol. 2012;73(5):691–705. © 2012 The Authors. British Journal of Clinical Pharmacology © 2012 The British Pharmacological Society.Citation8](/cms/asset/2529dc21-d728-4479-b169-54c4438ce946/dcop_a_170848_f0001_c.jpg)
Table 1 Methods of evaluating medication adherence in COPD at the patient level
Figure 2 The INCA system. which is an open-access article distributed under the terms of the creative commons attribution license, permitting its unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
![Figure 2 The INCA system. which is an open-access article distributed under the terms of the creative commons attribution license, permitting its unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.](/cms/asset/7520a2a1-d299-4810-9122-9d3c59c0030f/dcop_a_170848_f0002_b.jpg)
Box 1 Factors associated with treatment adherence